|
RG9MTD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.717500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.383790E-01 |
| Normal-vs-Stage2 |
7.082500E-02 |
| Normal-vs-Stage3 |
7.813700E-02 |
| Normal-vs-Stage4 |
6.115600E-02 |
| Stage1-vs-Stage2 |
5.223000E-01 |
| Stage1-vs-Stage3 |
4.178200E-01 |
| Stage1-vs-Stage4 |
2.478800E-01 |
| Stage2-vs-Stage3 |
9.387000E-01 |
| Stage2-vs-Stage4 |
4.339400E-01 |
| Stage3-vs-Stage4 |
5.304000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.597100E-03 |
| Normal-vs-AfricanAmerican |
2.074400E-01 |
| Normal-vs-Asian |
4.679800E-01 |
| Caucasian-vs-AfricanAmerican |
4.604800E-01 |
| Caucasian-vs-Asian |
9.689600E-01 |
| AfricanAmerican-vs-Asian |
8.074600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.878880E-03 |
| Normal-vs-Female |
6.389600E-01 |
| Male-vs-Female |
5.062500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.734600E-01 |
| Normal-vs-Extreme_Weight |
9.523500E-03 |
| Normal-vs-Obese |
9.742400E-03 |
| Normal-vs-Extreme_Obese |
8.768600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.242200E-01 |
| Normal_Weight-vs-Obese |
4.864800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.154400E-01 |
| Extreme_Weight-vs-Obese |
9.406800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.111200E-01 |
| Obese-vs-Extreme_Obese |
3.389000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.374600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.444200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.943620E-02 |
| Normal-vs-Age(81-100Yrs) |
2.742000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.496160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.834230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.397800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.353800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.582400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.820000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.299420E-01 |
| Normal-VS-Type2 PRCC |
1.357650E-02 |
| Normal-VS-KIRP CIMP |
4.135800E-03 |
| Normal-VS-Unclassified PRCC |
3.576600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.142370E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.533200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.324000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.895400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.571600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.652000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.14740000000258E-05 |
| Normal-vs-N1 |
4.113800E-01 |
| Normal-vs-N2 |
2.82989999988992E-07 |
| N0-vs-N1 |
7.048100E-02 |
| N0-vs-N2 |
3.709800E-02 |
| N1-vs-N2 |
1.842060E-02 |
|
|
